USP53 and hepatocellular carcinoma: This was consistent with the expression trend of USP53 in lung cancer [14], renal clear cell carcinoma [15], hepatocellular carcinoma [16] and esophageal carcinoma [17], and it acted as a tumor suppressor in these cancers, so we speculated that USP53 should play the similar role in breast cancer.